Two Compounds Sourced From Cannabis Show Promising Anti-Cancer Effects

Cannabis Compounds Stop Ovarian Cancer Cells From Surviving in Lab Tests

The compounds worked by disrupting energy production, triggering programmed cell death, and blocking the molecular signals that tumors need to survive. The post Cannabis Compounds Stop Ovarian Cancer Cells From Surviving in Lab Tests appeared first on Study Finds.

Cannabis compounds show unexpected power against ovarian cancer

Scientists have discovered that key compounds from cannabis—CBD and THC—show surprisingly strong effects against ovarian cancer cells. Used together, they slow cell growth, reduce colony formation, and may even block the cancer’s ability to spread. Even more promising, the treatment caused minimal harm to healthy cells and appears to work by restoring a disrupted signaling pathway that fuels tumor growth.

Two compounds sourced from cannabis show promising anti-cancer effects

In the future, scientists could use drugs made from cannabis to fight ovarian cancer. A team of scientists testing the effects of two chemical compounds sourced from cannabis on ovarian cancer cells have found that both show promising anti-cancer effects.

Cannabinoids Show Promising Effects in Ovarian Cancer Cells

A team of scientists testing the effects of CBD and THC on ovarian cancer cells have found that both show promising anti-cancer effects.  While still in the early stages, researchers say these preliminary findings from the laboratory present an important opportunity to develop effective new therapies for a cancer that is hard to diagnose and even harder to treat.  Ovarian cancer kills more patients than any other gynecological cancer, affecting …

Cannabinoids Halt Ovarian Cancer Growth via Cell Cycle Pathway

Researchers in Thailand have discovered that a combination of CBD and THC can effectively kill ovarian cancer cells and stop their growth while sparing healthy cells. A study published today in Frontiers in Pharmacology shows, for the first time, how both compounds act synergistically to regulate the PI3K/AKT/mTOR pathway, which is known to drive cancer growth and treatment resistance in ovarian cancer cells. “Although our study is still prelimi…